A new study shows risks for premature death associated with CUD. Others show increased memory problems, CUD, depression, ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...
A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...
Hosted on MSN10d
Cases of schizophrenia linked to cannabis use disorder have almost tripled over the past 17 years: StudyThe proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...
Cannabis is gaining widespread appeal and a growing number of U.S. states are approving medical marijuana. A large study ...
The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal ...
The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...
Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, ...
A new Canadian study shows a tripling of schizophrenia cases linked to cannabis use disorder since the country legalized it.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback